HRS 2014 Roundup

The 2014 Heart Rhythm Society Scientific Sessions ended May 10 in San Francisco with a big study from Boston Scientific Corp. on the benefits of implantable cardioverter defibrillator remote monitoring. Results of the PREDICt-RM study show that remote monitoring with the firm’s Latitude Patient Monitoring System reduces mortality and hospitalization rates. PREDICt-RM combined data from Boston Scientific’s ALTITUDE Registry and the National Cardiovascular Data Registry ICD Registry to follow 37,742 first-time ICD or cardiac resynchronization therapy (CRT)-defibrillator patients for at least three years post-implant. The investigators compared all-cause mortality and hospitalization rates in patients who used remote monitoring and those who did not take advantage of remote monitoring even though their ICD was compatible with Latitude.

During the three-year follow-up period, results from PREDICt-RM showed that patients whose doctors monitored their ICD or CRT-D with Latitude...